Key result
Elevated Lp(a) is linked to increased ASCVD risk and requires targeted management strategies.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
This article provides an overview of lipoprotein(a), its association with atherosclerotic cardiovascular disease risk, and management strategies.
This JAMA Insights discusses lipoprotein(a), including factors associated with elevated lipoprotein(a) levels, how to manage them, and atherosclerotic cardiovascular disease risk.
No takes yet. Share an insight, caveat, or question.
Mora et al. (2025) studied this question. Lipoprotein(a) is a key biomarker whose elevated levels are linked to atherosclerotic cardiovascular disease risk and require specific management strategies.
Synapse has enriched 10 related papers. Consider them for comparative context: